Human AGXT ELISA Kit (V2LY-0626-LY5234)

Li, Y., Zheng, R., Xu, G., Huang, Y., Li, Y., Li, D., & Geng, H. (2021). Generation and characterization of a novel rat model of primary hyperoxaluria type 1 with a nonsense mutation in alanine-glyoxylate aminotransferase gene. American Journal of Physiology-Renal Physiology, 320(3), F475-F484.

Wang, W., Li, J., Ning, C., & Tian, Y. (2020). Mutational analysis of AGXT gene in Chinese patients with primary hyperoxaluria type 1. Journal of Pediatric Urology, 16, S48-S49.

Sun, Y., Li, W., Shen, S., Yang, X., Lu, B., Zhang, X., ... & Ji, J. (2019). Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis. Journal of translational medicine, 17(1), 1-16.

Lu, X., Chen, W., Li, L., Zhu, X., Huang, C., Liu, S., ... & Zhao, Y. (2019). Two novel AGXT mutations cause the infantile form of primary hyperoxaluria type I in a Chinese family: Research on missed mutation. Frontiers in pharmacology, 10, 85.

Li, X., Gu, J., Yang, Y., Li, J., & Li, Y. (2018). A putative mutation hotspot of the AGXT gene associated with primary Hyperoxaluria type 1 in the Chinese population. The Tohoku journal of experimental medicine, 246(4), 233-241.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols